(Q44619029)

4 December 2017

CYR61: a new measure of lung cancer outcome (English)

1 reference

4 December 2017

Akio Mori

1

1 reference

4 December 2017

Julian C Desmond

2

1 reference

4 December 2017

Naoki Komatsu

3

1 reference

4 December 2017

James O'Kelly

4

1 reference

4 December 2017

Carl W Miller

5

1 reference

4 December 2017

Ronald Legaspi

6

1 reference

4 December 2017

Alberto M Marchevsky

7

1 reference

4 December 2017

Robert J McKenna

8

1 reference

4 December 2017

H Phillip Koeffler

9

1 reference

4 December 2017

1 December 2007

1 reference

4 December 2017

1 reference

4 December 2017

25

1 reference

4 December 2017

8

1 reference

4 December 2017

738-741

1 reference

Expression of cyr61, a growth factor-inducible immediate-early gene

4 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

The CCN family: a new stimulus package

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

The CCN family of angiogenic regulators: the integrin connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

CCN proteins: multifunctional signalling regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

Expression of the extracellular matrix signaling molecule Cyr61 is downregulated in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

Cyr61 suppresses growth of human endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900701512597

10.1080/02770900701512597

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference